News

Investors Alert: Action Required for Stellantis Case by Deadline

Investors Alert: Action Required for Stellantis Case by Deadline

Important Reminder for Stellantis Investors

It is crucial for investors in Stellantis N.V. to stay updated on a significant deadline. Glancy Prongay & Murray LLP is here to remind you that if you purchased or acquired securities of Stellantis during the Class Period, which spans certain dates in 2024, you have until October 15, 2024, to take necessary action.

Details of the Class Action Lawsuit

This class action lawsuit has been initiated on behalf of investors who bought Stellantis securities between February 15, 2024, and July 24, 2024. The deadline for filing a lead plaintiff motion is drawing near, and it is important for affected investors to be represented.

How to Participate in the Lawsuit

If you experienced a loss due to your investment in Stellantis, there are options available to recover your losses. Investors wishing to learn more about their rights are encouraged to reach out to Glancy Prongay & Murray LLP for assistance.

Concerns Raised in Financial Disclosures

On July 25, 2024, Stellantis released its semi-annual financial report for the initial half of 2024. The report indicated that the company had failed to meet the consensus estimates, leading to concerns regarding its future performance and financial stability. The report revealed a disappointing near-term outlook that significantly impacted investor confidence.

Impact of Financial Results on Stock Performance

The disappointing financial disclosures led to a sharp decline in Stellantis' stock value, with the price dropping by $1.94, which is a notable 9.9% decrease over two days. On July 26, 2024, Stellantis shares closed at $17.66 per share, raising alarms among investors.

Allegations in the Class Action Complaint

The class action complaint asserts that throughout the Class Period, Stellantis and its executives made materially false or misleading statements, while failing to disclose important facts about the company’s operational challenges. Investors were unaware of significant issues such as revenue shortfalls and unsuccessful business expansions, which were not adequately communicated to them.

Investors’ Rights and Actions

If you were a part of the class of investors who acquired Stellantis securities during the defined periods, you are encouraged to act swiftly. Appointments as a lead plaintiff can be requested through the court before the specified deadline. Those who choose not to take action at this juncture can still maintain their status as a member of the class.

Stay Informed and Connected

Investors seeking ongoing updates and information about the Stellantis case can connect with Glancy Prongay & Murray LLP through various platforms. Keeping in touch can help ensure you are aware of any significant developments pertaining to the lawsuit.

Frequently Asked Questions

1. What is the deadline for the Stellantis class action lawsuit?

The deadline for filing a lead plaintiff motion in the class action lawsuit is October 15, 2024.

2. What should I do if I invested in Stellantis during the Class Period?

If you purchased Stellantis securities during the Class Period, you should consult with a lawyer or contact Glancy Prongay & Murray LLP for guidance on potentially recovering your losses.

3. How did Stellantis' financial report impact its stock?

The company’s financial report indicated that it recorded disappointing results, leading to a significant decline in stock value by nearly 10% over two trading days.

4. What are the main allegations against Stellantis?

Allegations in the complaint assert that Stellantis made false statements and withheld critical information regarding its financial performance from investors.

5. How can I stay updated on the case?

Investors can follow Glancy Prongay & Murray LLP on various social media platforms for updates on the class action lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Huawei Unveils WATCH D3 as Blood Pressure Pioneer

Updated Category News Views 17

A Fresh Step in Wearable Health Tech Today's news out of Munich got my attention—Huawei has tossed their hat into the ring of wrist-based health tech yet again with their new HUAWEI WATCH D3. Unveiled early at the European Society of Cardiology Congress 2026, this isn't just another flashy gadget. It's a serious play for the future of blood pressure management, bridging...

Continue Reading
Pye-Barker's Bold Move: Northwest Expansion in Fire Safety

Updated Category News Views 8

Tapping into the Pacific Northwest Potential Pye-Barker Fire & Safety has made quite a splash with its most recent move: acquiring Suppression Systems, Inc. If you've been watching the growth and acquisitions game lately, you know it's less about just adding a new set of offices—this is about deepening expertise in a region that's practically begging for robust fire...

Continue Reading
Daraxonrasib: New Lifeline for Metastatic Pancreatic Cancer

Updated Category News Views 6

New Hope on the Horizon Some medical breakthroughs feel like rays of sunshine breaking through dense clouds, and this one is no different. Karmanos Cancer Institute, a pillar of cancer research for over seven decades, has added a new weapon to its arsenal with the introduction of daraxonrasib (Rasonque) for metastatic pancreatic cancer patients. Approved by the FDA on...

Continue Reading
Genomma's $1B Debt Plan Spurs Growth Prospects

Updated Category News Views 5

Genomma Secures Major Credit Facility Ever seen a company juggle debt like a pro? That's exactly what Genomma Lab Internacional is up to with their latest move. They've locked in a hefty MXN $1 billion long-term credit facility with Banamex. Now, if that doesn't catch a trader's eye, I don't know what does! Aiming for Financial Reconfiguration The credit they secured...

Continue Reading
Oligonucleotide CDMO Market: Big Growth Potential by 2031

Updated Category News Views 7

Why Oligonucleotide CDMO is Worth a Closer Look Here's a sector that's quietly sprinting from a tiny corner of biotech into something massive. The Oligonucleotide CDMO market, projected to hit $11.14 billion by 2031, is in full swing. That's no small feat when you consider how quickly it's expected to grow from a modest $3.88 billion in 2026, marking a whopping 23.5%...

Continue Reading
HUMAIN and KORA Revamp OS with AI at Core, 2027 Launch

Updated Category News Views 5

Rethinking the Operating System Landscape The world of computing is about to get shaken up like a snow globe. HUMAIN and KORA are gambling big by melding artificial intelligence right into the beating heart of the operating system. This isn't about slapping on an AI app as an afterthought. Nope, they’re baking the smarts directly into the OS with their new HUMAIN OS—a...

Continue Reading
FedEx Faces Lawsuit Over Sleeping Truck Driver Incident

Updated Category News Views 1

A Trucker's Nightmare Leads to the Courtroom Talk about a situation where everything just falls apart. Over in Harris County, Texas, a FedEx driver allegedly dozed off at the wheel last November, and it all went downhill from there. Bam—truck hits a vehicle, and now it's lawsuit time. The driver, by his own admission, lost his focus for a moment on the road while...

Continue Reading
Enhancing Your Home: Decorative Concrete Options Explored

Updated Category News Views 6

Transforming Concrete from Plain to Spectacular Concrete's reputation for being as bland as overcooked oatmeal might finally be getting a makeover, and it's happening right in homes across Western New York. The magic lies in decorative concrete coatings, those slick transformations courtesy of some savvy tech and design wizardry. HelloNation breaks it down with insights...

Continue Reading
ActivatedYou Wins Skin Award: A Closer Look

Updated Category News Views 0

Taking Note of ActivatedYou's Triumph So here we have it, folks. ActivatedYou's Essential Skin Food sauntered away with the 'Collagen Product of the Year' award at none other than the 2026 Mindful Awards. Let me tell you, in the convoluted world of supplements and beauty products, standing out ain't an easy feat. But this right here is a moment worth crowing about. Their...

Continue Reading
SuperSprings & B&W Unite for Top Adapter Innovation

Updated Category News Views 3

A Game-Changer in Towing Adaptation You think swapping a fifth wheel for a gooseneck is easy-peasy? Not unless you've got an award-winning adapter on your hands. SuperSprings International and B&W Trailer Hitches have set the bar sky-high with their latest creation—a fifth wheel to gooseneck adapter making waves in the market. Winning Big in the RV Market This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Adcendo ApS Welcomes New Leaders to Drive Innovation

Updated Category News Views 190

Adcendo ApS Welcomes New Leaders to Drive Innovation Adcendo, a pioneering biotech firm focused on developing cutting-edge antibody-drug conjugates (ADCs) for cancer treatment, is set to embark on an exciting new chapter following significant leadership changes. The company recently announced two crucial appointments to its Board of Directors and a key addition to its...

Continue Reading
B2B Manufacturers Embrace AI to Enhance eCommerce Performance

Updated Category News Views 127

Transforming the B2B Landscape with AI Innovations In today's rapidly evolving market, B2B retailers and manufacturers are making significant strides in adopting AI-driven eCommerce solutions. A recent study highlights the impactful transformations occurring in this sector, showcasing how businesses are increasingly harnessing the power of Artificial Intelligence to...

Continue Reading
Sungrow's PowerTitan 2.0: Revolutionary Breakthrough in Energy Storage

Updated Category News Views 110

Innovation Recognized at Major Renewable Energy Awards Sungrow, a prominent name in the field of renewable energy technology, proudly announces that its PowerTitan 2.0 energy storage system has been honored with the Storage Product Innovation Award at a significant industry awards event. This recognition highlights the company's dedication to advancing energy solutions...

Continue Reading
J&J's Bispecific Combo Excels in Myeloma Study

Updated Category News Views 13

Game-Changing Results in Myeloma Treatment Ah, Johnson & Johnson, always pushing the envelope in cancer treatment. Their latest Phase 3 study featuring TALVEY® and DARZALEX FASPRO®, with or without pomalidomide, might just be the proverbial ace up their sleeve. The MonumenTAL-3 study results, presented at the European Hematology Association's big bash, show some...

Continue Reading
Projected Surge in Database Security Revenue to $20.9 Billion

Updated Category News Views 138

Back in 2024, the buzz around the database security market was palpable—traders were eyeing a sector expected to balloon to USD 20.9 billion by 2032. That kind of growth don’t just happen on its own; it came with a compound annual growth rate (CAGR) of 12.48%, which made folks sit up and take notice. The whole scene was driven by businesses drowning in data while...

Continue Reading